Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1976 Mar;49(1):45–58.

Cytomegalovirus Replication and the Host Immune Response 1

D J Lang, K S Cheung, J N Schwartz, C A Daniels, S E Harwood
PMCID: PMC2595322  PMID: 183380

Abstract

Cytomegalovirus (CMV) is closely associated with host cellular structures, and this has a significant impact upon the immunologic response following infection. CMV may be recovered from a variety of body secretions and fluids during acute infection, and protracted shedding may supervene in some instances. The reasons for a variable host response to CMV infection remain unclear, and the mechanisms responsible for the establishment of persistence have not been worked out. CMV persistence and latency are discussed, and some recently derived relevant data are presented. An animal model has been developed consistent with clinical observations pertaining to CMV transmission with blood. Results obtained in the course of these and other studies support the concept of immunological activation of latent CMV. The timing of CMV infection relative to an unrelated antigenic challenge is probably critical in determining the emergence of immunodepression or enhancement. Some aspects of CMV sero-diagnosis are also reviewed.

Full text

PDF
45

Images in this article

46FIG. 1
on p.46
47FIG. 2
on p.47
49FIG. 3
on p.49
49FIG. 4
on p.49
51FIG. 5
on p.51
55FIG. 6
on p.55

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albrecht T., Rapp F. Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus. Virology. 1973 Sep;55(1):53–61. doi: 10.1016/s0042-6822(73)81007-4. [DOI] [PubMed] [Google Scholar]
  2. Benyesh-Melnick M., Probstmeyer F., McCombs R., Brunschwig J. P., Vonka V. Correlation between infectivity and physical virus particles in human cytomegalovirus. J Bacteriol. 1966 Nov;92(5):1555–1561. doi: 10.1128/jb.92.5.1555-1561.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CRAIG J. M., MACAULEY J. C., WELLER T. H., WIRTH P. Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease. Proc Soc Exp Biol Med. 1957 Jan;94(1):4–12. doi: 10.3181/00379727-94-22841. [DOI] [PubMed] [Google Scholar]
  4. Dent P. B. Immunodepression by oncogenic viruses. Prog Med Virol. 1972;14:1–35. [PubMed] [Google Scholar]
  5. Farber S., Wolbach S. B. Intranuclear and Cytoplasmic Inclusions ("Protozoan-Like Bodies") in the Salivary Glands and Other Organs of Infants. Am J Pathol. 1932 Mar;8(2):123–136.3. [PMC free article] [PubMed] [Google Scholar]
  6. Gerber P. Studies on the transfer of subviral infectivity from SV40-induced hamster tumor cells to indicator cells. Virology. 1966 Apr;28(4):501–509. doi: 10.1016/0042-6822(66)90234-0. [DOI] [PubMed] [Google Scholar]
  7. Hanshaw J. B., Steinfeld H. J., White C. J. Fluorescent-antibody test for cytomegalovirus macroglobulin. N Engl J Med. 1968 Sep 12;279(11):566–570. doi: 10.1056/NEJM196809122791102. [DOI] [PubMed] [Google Scholar]
  8. Harnden D. G., Elsdale T. R., Young D. E., Ross A. The isolation of cytomegalovirus from peripheral blood. Blood. 1967 Jul;30(1):120–125. [PubMed] [Google Scholar]
  9. Hirsch M. S., Black P. H. Activation of mammalian leukemia viruses. Adv Virus Res. 1974;19:265–313. doi: 10.1016/s0065-3527(08)60662-4. [DOI] [PubMed] [Google Scholar]
  10. Huang E. S., Pagano J. S. Human cytomegalovirus. II. Lack of relatedness to DNA of herpes simples I and II, Epstein-Barr virus, and nonhuman strains of cytomegalovirus. J Virol. 1974 Mar;13(3):642–645. doi: 10.1128/jvi.13.3.642-645.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kane R. C., Rousseau W. E., Noble G. R., Tegtmeier G. E., Wulff H., Herndon H. B., Chin T. D., Bayer W. L. Cytomegalovirus infection in a volunteer blood donor population. Infect Immun. 1975 Apr;11(4):719–723. doi: 10.1128/iai.11.4.719-723.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kieff E., Levine J. Homology between Burkitt herpes viral DNA and DNA in continuous lymphoblastoid cells from patients with infectious mononucleosis. Proc Natl Acad Sci U S A. 1974 Feb;71(2):355–358. doi: 10.1073/pnas.71.2.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Käriäinen L., Klemola E., Paloheimo J. Rise of cytomegalovirus antibodies in an infectious-mononucleosis-like syndrome after transfusion. Br Med J. 1966 May 21;1(5498):1270–1272. doi: 10.1136/bmj.1.5498.1270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lang D. J. Cytomegalovirus infections in organ transplantation and post transfusion. An hypothesis. Arch Gesamte Virusforsch. 1972;37(4):365–377. doi: 10.1007/BF01241460. [DOI] [PubMed] [Google Scholar]
  15. Lang D. J., Kummer J. F. Cytomegalovirus in semen: observations in selected populations. J Infect Dis. 1975 Oct;132(4):472–473. doi: 10.1093/infdis/132.4.472. [DOI] [PubMed] [Google Scholar]
  16. Lang D. J., Noren B. Cytomegaloviremia following congenital infection. J Pediatr. 1968 Dec;73(6):812–819. doi: 10.1016/s0022-3476(68)80233-1. [DOI] [PubMed] [Google Scholar]
  17. London W. T., Di Figlia M., Sutnick A., Blumberg B. S. An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response. N Engl J Med. 1969 Sep 11;281(11):571–578. doi: 10.1056/NEJM196909112811101. [DOI] [PubMed] [Google Scholar]
  18. Maurer B. A., Wilbert S. M., Imamura T. Incidence of EB virus-containing cells in primary and secondary clones of several Burkitt lymphoma cell lines. Cancer Res. 1970 Dec;30(12):2870–2875. [PubMed] [Google Scholar]
  19. Miller M. H., Stitt D., Miller G. Epstein-Barr viral antigen in single cell clones of two human leukocytic lines. J Virol. 1970 Nov;6(5):699–701. doi: 10.1128/jvi.6.5.699-701.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mirkovic R., Werch J., South M. A., Benyesh-Melnick M. Incidence of cytomegaloviremia in blood-bank donors and in infants with congenital cytomegalic inclusion disease. Infect Immun. 1971 Jan;3(1):45–50. doi: 10.1128/iai.3.1.45-50.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nonoyama M., Pagano J. S. Detection of Epstein-Barr viral genome in nonproductive cells. Nat New Biol. 1971 Sep 22;233(38):103–106. doi: 10.1038/newbio233103a0. [DOI] [PubMed] [Google Scholar]
  22. Olding L. B., Jensen F. C., Oldstone M. B. Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction. J Exp Med. 1975 Mar 1;141(3):561–572. doi: 10.1084/jem.141.3.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Oldstone M. B. Virus neutralization and virus-induced immune complex disease. Virus-antibody union resulting in immunoprotection or immunologic injury--two sides of the same coin. Prog Med Virol. 1975;19:84–119. [PubMed] [Google Scholar]
  24. Osborn J. E., Blazkovec A. A., Walker D. L. Immunosuppression during acute murine cytomegalovirus infection. J Immunol. 1968 Apr;100(4):835–844. [PubMed] [Google Scholar]
  25. Osborn J. E., Medearis D. N., Jr Suppression of interferon and antibody and multiplication of Newcastle disease virus in cytomegalovirus infected mice. Proc Soc Exp Biol Med. 1967 Feb;124(2):347–353. doi: 10.3181/00379727-124-31740. [DOI] [PubMed] [Google Scholar]
  26. Park S. K., Brody J. I., Wallace H. A., Blakemore W. S. Immunosuppressive effect of surgery. Lancet. 1971 Jan 9;1(7689):53–55. doi: 10.1016/s0140-6736(71)90777-x. [DOI] [PubMed] [Google Scholar]
  27. Payne J. E., Fiala M., Spencer M., Chatterjee S. N., Berne T. V. Cytomegalovirus antigen-antibody complexes in biopsy specimens in renal allograft rejection. Surg Forum. 1974;25(0):273–275. [PubMed] [Google Scholar]
  28. SMITH M. G. Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease. Proc Soc Exp Biol Med. 1956 Jun;92(2):424–430. doi: 10.3181/00379727-92-22498. [DOI] [PubMed] [Google Scholar]
  29. Schwartz J. N., Daniels C. A., Shivers J. C., Klintworth G. K. Experimental cytomegalovirus ophthalmitis. Am J Pathol. 1974 Dec;77(3):477–492. [PMC free article] [PubMed] [Google Scholar]
  30. Selgrade M. K., Osborn J. E. Role of macrophages in resistance to murine cytomegalovirus. Infect Immun. 1974 Dec;10(6):1383–1390. doi: 10.1128/iai.10.6.1383-1390.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Simmons R. L., Lopez C., Balfour H., Jr, Kalis J., Rattazzi L. C., Najarian J. S. Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg. 1974 Oct;180(4):623–634. doi: 10.1097/00000658-197410000-00028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Stern H. Isolation of cytomegalovirus and clinical manifestations of infection at different ages. Br Med J. 1968 Mar 16;1(5593):665–669. doi: 10.1136/bmj.1.5593.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Stulberg C. S., Zuelzer W. W., Page R. H., Taylor P. E., Brough Cytomegalovirus infections with reference to isolations from lymph nodes and blood. Proc Soc Exp Biol Med. 1966 Dec;123(3):976–982. doi: 10.3181/00379727-123-31651. [DOI] [PubMed] [Google Scholar]
  34. WELLER T. H., HANSHAW J. B., SCOTT D. E. Serologic differentiation of viruses responsible for cytomegalic inclusion disease. Virology. 1960 Sep;12:130–132. doi: 10.1016/0042-6822(60)90156-2. [DOI] [PubMed] [Google Scholar]
  35. Waner J. L., Weller T. H., Kevy S. V. Patterns of cytomegaloviral complement-fixing antibody activity: a longitudinal study of blood donors. J Infect Dis. 1973 May;127(5):538–543. doi: 10.1093/infdis/127.5.538. [DOI] [PubMed] [Google Scholar]
  36. Weller T. H. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. II. N Engl J Med. 1971 Jul 29;285(5):267–274. doi: 10.1056/NEJM197107292850507. [DOI] [PubMed] [Google Scholar]
  37. Wu B. C., Dowling J. N., Armstrong J. A., Ho M. Enhancement of mouse cytomegalovirus infection during host-versus-graft reaction. Science. 1975 Oct 3;190(4209):56–58. doi: 10.1126/science.170676. [DOI] [PubMed] [Google Scholar]
  38. Zajac B. A., Kohn G. Epstein-Barr virus antigens, marker chromosome, and interferon production in clones derived from cultured Burkitt tumor cells. J Natl Cancer Inst. 1970 Aug;45(2):399–406. [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES